Showing results (291-300 of 1,061) with videos related to
Sort By:
Pageof 107
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's diseaseCorinne E Fischer, Winnie Qian, Tom A Schweizer, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB studyJaren W Landen, Niels Andreasen, Carol L Cronenberger, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Phase II clinical trials of anti-amyloid β antibodies: When is enough, enough?Michael GoldAlzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analysesMartijn C de Wilde, Bruno Vellas, Elodie Girault, et al.Alzheimer'S & Dementia (New York, N. Y.)|May 2, 2022
Cognitive and physical benefits of a game-like dual-task exercise among the oldest nursing home residents in JapanJieun Yoon, Hiroko Isoda, Tetsuya Ueda, et al.Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Measurement of neurodegeneration using a multivariate early frame amyloid PET classifierDawn C Matthews, Ana S Lukic, Randolph D Andrews, et al.Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Factor structure of Pre-Loss Grief-12 in caregivers of people living with dementiaJuyoung Park, Hannah Levine, James E GalvinAlzheimer'S & Dementia (New York, N. Y.)|September 4, 2018
Advances in functional magnetic resonance imaging data analysis methods using Empirical Mode Decomposition to investigate temporal changes in early Parkinson's diseaseDietmar Cordes, Xiaowei Zhuang, Muhammad Kaleem, et al.Alzheimer'S & Dementia (New York, N. Y.)|September 20, 2019
Perceptions of precision medicine among diverse dementia caregivers and professional providersJoseph E Gaugler, Hayley R McCarron, Lauren L MitchellAlzheimer'S & Dementia (New York, N. Y.)|November 15, 2018
The Cognitive Ageing, Nutrition and Neurogenesis (CANN) trial: Design and progressMichael A Irvine, Andrew Scholey, Rebecca King, et al.Pageof 107